OverviewSuggest Edit

OncoMark Ltd. is a private company centred on the development and application of biomarker panels, particularly supporting oncology drug development. A major focus of the company is to provide the link from -omic level discovery to validation via the use of multiplex antibody-based assays and high-throughput tissue microarray screening. OncoMark also conducts in-house research and development to create unique multi-marker assays for use in the discrimination of patient response to drug therapies and apply novel in-house image analysis toolkit for assessment of IHC-based markers at the subcellular compartmental level. This is of particular benefit to the pharmaceutical and health authority sectors.

TypePrivate
Founded2007
HQDublin 4, IE
Websiteoncomark.com

Latest Updates

Employees (est.) (Apr 2022)5
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Oncomark

Desmond OLeary

Desmond OLeary

CEO
Stephen Penney

Stephen Penney

CFO
William Gallagher

William Gallagher

Chief Scientific Officer
Máirín Rafferty

Máirín Rafferty

Chief Operations Officer
Show more

Oncomark Office Locations

Oncomark has an office in Dublin 4
Dublin 4, IE (HQ)
NovaUCD, Innovation Park, UCD, Belfield
Show all (1)

Oncomark Financials and Metrics

Summary Metrics

Founding Date

2007

Oncomark total Funding

$4.9 m

Oncomark latest funding size

$2.22 m

Time since last funding

5 years ago

Oncomark investors

Oncomark's latest funding round in February 2017 was reported to be $2.2 m. In total, Oncomark has raised $4.9 m
Show all financial metrics

Oncomark Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Oncomark Online and Social Media Presence

Embed Graph

Oncomark Blogs

December 2019: OncoMasTR Clinical Validation Study Published in Peer-Reviewed Journal Clinical Cancer Research

Clinical Cancer Research Published a Key Study on the Clinical Validity of OncoMasTR Conducted by Researchers from The Institute of Cancer Research, Royal Marsden Hospital and Queen Mary University of London. The clinical validation study of OncoMasTR has been published in a peer-reviewed and hig…

November 2019: OncoMark Founder Professor William Gallagher Receives the 2019 Science Foundation Ireland Entrepreneurship Award

OncoMark founder and Chief Scientific Officer Professor William Gallagher has been announced as winner of the prestigious 2019 Science Foundation Ireland (SFI) Entrepreneurship Award at the annual SFI Science Summit held in Athlone. A major focus of Professor Gallagher’s research at UCD is the ide…

November 2019: OncoMark Founder Receives Award

OncoMark founder and Chief Scientific Officer Professor William Gallagher has been announced as winner of the prestigious 2019 Science Foundation Ireland (SFI) Entrepreneurship Award at the annual SFI Science Summit held in Athlone. A major focus of Professor Gallagher’s research at UCD is the ide…

June 2019: OncoMark to present results from a key study at ASCO 2019

OncoMark to Present Key Study on OncoMasTR Test for Early Stage Breast Cancer at ASCO 2019 in Chicago Presentation will highlight superior clinical performance of the OncoMasTR test in Irish patients enrolled in the TAILORx Trial OncoMark Ltd (www.oncomark.com) will be presenting results from …

October 2018: OncoMark attending ESMO

October 2018: OncoMark to attend the European Society of Medical Oncology (ESMO) 2018 Congress Members of the OncoMark team will be attending the European Society of Medical Oncology 2018 Congress in Munich, Germany, from the 19th- 22nd October. Mr. Des O’Leary (CEO), Mr William Gallagher (Chief S…

August 2018 - OncoMasTR test CE marked

  OncoMark Ltd are proud to announce the CE marking of the OncoMasTR test. OncoMark today announced its declaration of conformity to the European In Vitro Diagnostic Directive 98/79/EC and CE mark of OncoMasTR, a gene expression profiling test for early-stage breast cancer prognosis. The OncoMa…
Show more

Oncomark Frequently Asked Questions

  • When was Oncomark founded?

    Oncomark was founded in 2007.

  • Who are Oncomark key executives?

    Oncomark's key executives are Desmond OLeary, Stephen Penney and William Gallagher.

  • How many employees does Oncomark have?

    Oncomark has 5 employees.

  • Who are Oncomark competitors?

    Competitors of Oncomark include Cipla, Alembic Pharmaceuticals and EMS Pharma.

  • Where is Oncomark headquarters?

    Oncomark headquarters is located at NovaUCD, Innovation Park, UCD, Belfield, Dublin 4.

  • Where are Oncomark offices?

    Oncomark has an office in Dublin 4.

  • How many offices does Oncomark have?

    Oncomark has 1 office.